3-Chloro-4-fluorobenzaldehyde

We are 3-Chloro-4-fluorobenzaldehyde CAS:34328-61-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-Chloro-4-fluorobenzaldehyde
CAS.NO:34328-61-5
Synonyms:4-fluoro-3-chlorobenzaldehyde; 
3-chloro-4-fluoro benzaldehyde;
Molecular Formula:C7H4ClFO
Molecular Weight:158.55700
 
Physical and Chemical Properties:
Density:1.207;
Melting point:28-30oC;
Boiling point:66oC;
Flash point:230oF;
Index of Refraction:1.544-1.546;
 
Specification:
Appearance:Colorless to light yellow crystalline powder
Purity(GC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis
 

3-Chloro-4-fluorobenzaldehyde


Related News: In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.2,4-Dichloro-5-(trifluoromethyl)pyrimidine CAS:3932-97-6 The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.2-Bromo-11,11-dimethyl-11H-benzo[b]fluorene The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.14777-27-6 Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs.In order to find answers to these questions, our staff in the development department set about conducting a series of experiments.

Related Products
Product Name
2-chloro-1,4-naphthoquinone View Details
1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butane-1,3-dione View Details
4-(4-chlorophenyl)-N,N-diphenylaniline View Details
H-LEU-VAL-OH manufacturer 2′-(Trifluoromethyl)acetophenone manufacturer (2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-phenylbutanoic acid manufacturer Triethylmethylammonium chloride manufacturer 2-Chloro-4-dibenzofuran-4-yl-6-phenyl-[1,3,5]triazine manufacturer